Yellow fever vaccine
- Generic Name
- Yellow fever vaccine
- Brand Names
- Yf-vax
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- PY4EET359T
- Background
Yellow fever vaccine prevents against Yellow Fever, a viral hemorrhagic disease caused by the transmission of a flavivirus through the bite of an infected mosquito. Symptoms of Yellow fever can range from asymptomatic, to mild flu-like illness, to more severe symptoms such as shock, jaundice, internal bleeding, and organ failure . Interestingly, Yellow fever...
- Indication
Yellow Fever Vaccine is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories:
- Associated Conditions
- Yellow Fever
- Associated Therapies
- -
Yellow Fever Human Infection Model With YF-17D
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05901454
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
- Conditions
- Interventions
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 60
- Registration Number
- NCT04083430
- Locations
- 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
Yellow Fever Immune Response at Single Cell Resolution
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 6
- Registration Number
- NCT03458780
- Locations
- 🇺🇸
The Rockefeller University, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.